Glucagon effects on ischemic vasodilatation in the isolated rat heart

J Biomed Biotechnol. 2010:2010:231832. doi: 10.1155/2010/231832. Epub 2010 Mar 18.

Abstract

The myocardial reperfusion following ischemia leads to the ischemic vasodilation by affecting the release of various vasoactive substances, such as free radicals, NO, and histamine. In addition, some evidences suggest that glucagon itself may alter the release of those substances. In this study, we investigated the ischemic vasodilation of the isolated rat heart, as well as the concentrations of NO, TBARS, and histamine in the coronary venous effluent either in the presence or in the absence of glucagon. Our results showed that in the presence of glucagon, there was a faster restoration of coronary perfusion pressure during ischemic vasodilation compared to the absence of glucagon (124 +/- 5.6 versus 81 +/- 5.2 s) with no apparent changes in TBARS concentration. The glucagon's administration leads to the decreased release of histamine by approximately 35%. Biphasic release of NO in the presence of glucagon initially showed augmentation by 60%, followed by the significant attenuation of 45%.

MeSH terms

  • Analysis of Variance
  • Animals
  • Coronary Vessels / drug effects*
  • Coronary Vessels / physiology
  • Glucagon / pharmacology*
  • Heart / drug effects*
  • Histamine / metabolism
  • Models, Cardiovascular
  • Myocardial Ischemia / drug therapy*
  • Myocardial Ischemia / metabolism
  • Myocardial Ischemia / physiopathology
  • Myocardial Reperfusion
  • Myocardium / metabolism
  • Nitric Oxide / metabolism
  • Rats
  • Thiobarbituric Acid Reactive Substances / metabolism
  • Vasodilation / drug effects

Substances

  • Thiobarbituric Acid Reactive Substances
  • Nitric Oxide
  • Histamine
  • Glucagon